4//SEC Filing
Doyle John Brendan 4
Accession 0001062993-23-010091
CIK 0001455365other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:20 PM ET
Size
7.1 KB
Accession
0001062993-23-010091
Insider Transaction Report
Form 4
Doyle John Brendan
Chief Financial Officer
Transactions
- Award
Common Stock
2023-05-01+109,824→ 109,824 total - Award
Stock Option (right to buy)
2023-05-01+109,824→ 109,824 totalExercise: $1.65Exp: 2033-05-01→ Common Stock (109,824 underlying)
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]The option vests 25% on May 1, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.
Issuer
COGNITION THERAPEUTICS INC
CIK 0001455365
Entity typeother
Related Parties
1- filerCIK 0001840738
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:20 PM ET
- Size
- 7.1 KB